Our research reveals low awareness of DKA and ketone testing among type 2 diabetes patients on SGLT2 inhibitors, highlighting urgent education needs.
Our research finds that 37% of people with diabetes report poor quality sleep, and about half suffer from restless sleep or have trouble staying asleep.
This study explores how activity monitoring mobile apps and software impact overall health outcomes in PWT2, focusing on both physical and mental well-being.
